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OBJECTIVE — Toexaminetheassociationbetweenthemoisturestatusoftheskinofthefeet
with foot ulceration in subjects with diabetes.
RESEARCH DESIGN AND METHODS — A total of 379 subjects with diabetes were
examined. Assessment of peripheral neuropathy was based on neuropathy symptom score,
neuropathydisabilityscore,vibrationperceptionthreshold,andthe10-gmonoﬁlamentpercep-
tion. The moisture status of the skin of the feet was assessed using the visual test Neuropad.
RESULTS — Patients with foot ulceration had more severe peripheral neuropathy and more
often an abnormal Neuropad response. Multivariate logistic regression analysis demonstrated
that the odds of foot ulceration increased with measures of neuropathy but increased also with
an abnormal Neuropad response.
CONCLUSIONS — An abnormal Neuropad response correlates with foot ulceration in sub-
jectswithdiabetes.Thisﬁnding,ifconﬁrmedprospectively,suggeststhattheNeuropadtestmay
be included in the screening tests for the prediction of foot ulceration.
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D
amage of the peripheral sympa-
thetic nerves results in sudomotor
dysfunction, which manifests as
dry skin of the feet and may result in cal-
lus and/or ﬁssure formation and eventu-
allyinfootulceration(1,2).TheAmerican
Diabetes Association recommends exam-
ination of sudomotor function for the de-
tection of diabetic neuropathies (3);
however, the lack of speciﬁc equipment
has restricted the study of sudomotor
function and its contribution to foot ul-
ceration. The Neuropad test (miro Ver-
bandstoffe, Wiehl-Drabenderho ¨he,
Germany) is a novel visual test for the as-
sessmentofthemoisturestatusoftheskin
of the feet (4,5). The research hypothesis
we tested herein was that an abnormal
Neuropad response may be associated
with foot ulceration in subjects with
diabetes.
RESEARCH DESIGN AND
METHODS— A total of 379 adult
subjects were recruited in this study. Ex-
clusion criteria were age 75 years, an-
kle-brachial pressure index 0.5,
estimated creatinine clearance rate using
the formula of Cockcroft-Gault 30 ml/
min,amputation,signiﬁcantfootswelling
or infection, and causes of neuropathy
other than diabetes. The demographic
and clinical characteristics of the partici-
pants are shown in Table 1.
Assessment for peripheral neuropa-
thy was based on symptoms (neuropathy
symptomscore[NSS])andsigns(neurop-
athy disability score [NDS]), as described
previously (6). Moreover, we assessed vi-
bration perception threshold (VPT) using
a biothesiometer (Biomedical Instru-
ments, Newbury, OH) and the 10-g
Semmes-Weinstein monoﬁlament (Bailey
Instruments, Manchester, U.K.) percep-
tion. Monoﬁlament was applied three
times on three plantar sites (under the
great toe and ﬁrst and ﬁfth metatarsal
heads) (7,8). Inability to perceive the
monoﬁlament at any site was considered
abnormal. The Neuropad was applied for
10 min under the ﬁrst metatarsal head in
the sitting position at both feet and eval-
uated as normal (pink color) or abnormal
(blue color or any other combination of
colors) (4,5). Peripheral artery disease
was diagnosed in the presence of any of
thefollowing:historyofintermittentclau-
dicationorrevascularizationprocedureat
the leg arteries, diminished or nonpal-
pable pedal pulses, and ankle-brachial
pressure index 0.9.
Differences between the studied
groups were tested using parametric or
nonparametric methods according to the
speciﬁc indications, whereas a 
2 test was
used to compare categorical data. Univar-
iate and multivariate logistic regression
analyses (stepwise backward method)
were performed to look for associations
between the studied parameters with foot
ulceration. The area under the receiver
operating characteristic (ROC) curve of
variousestablishedriskfactorsforfootul-
cerationandoftheNeuropadtestwascal-
culated. The area under the ROC curve
indicates how informative a test for the
prediction of foot ulceration is. P values
0.05 were considered statistically
signiﬁcant.
RESULTS— Subjects with foot ulcer-
ation were mostly men and had longer
diabetes duration, worse glycemic con-
trol, and more often peripheral neuropa-
thy and peripheral artery disease than
subjects without foot ulceration. The val-
ues of the NSS, NDS, and VPT were
higher, whereas monoﬁlament insensa-
tion and an abnormal Neuropad result
were more often documented in patients
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ropad result was not different between
patients with neuropathic and neuro-
ischemic ulcers (P  0.30).
Univariate logistic regression analysis
showed that the odds of foot ulceration
increased with male sex; longer duration
of diabetes; worse diabetes control; in-
creasing NSS, NDS, and VPT; monoﬁla-
ment insensation; presence of peripheral
artery disease; and abnormal Neuropad
response. Multivariate logistic regression
analysis after adjustment for age, sex, du-
ration of diabetes, A1C, NSS, and periph-
eral artery disease status demonstrated
that the odds of foot ulceration increased
withhigherNDS,VPT,andmonoﬁlament
insensation as well as with an abnormal
Neuropad result (Table 1).
Thearea(SE)undertheROCcurve
for the identiﬁcation of patients with foot
ulceration of VPT 25 vs. 25 V was
0.76  0.02 (P  0.001; sensitivity
85.4%; speciﬁcity 67.6%), of NDS 6 vs.
6 was 0.76  0.02 (P  0.001; sensi-
tivity75.7%;speciﬁcity77.8%),ofmono-
ﬁlament result (insensation vs. sensation)
was 0.72  0.03 (P  0.001; sensitivity
57.4%; speciﬁcity 86.3%), and of the
Neuropad result (abnormal vs. normal)
was 0.71  0.03 (P  0.001; sensitivity
97.1%; speciﬁcity 49.3%). The area un-
der the ROC curve of Neuropad testing
did not differ signiﬁcantly from that of
VPT, NDS, and monoﬁlament examina-
tion. No adverse events were observed
from the Neuropad use.
CONCLUSIONS — This study has
shown that dryness of the skin of the feet
correlates with foot ulceration. Subclini-
cal sudomotor dysfunction can be de-
Table 1—Demographic and clinical characteristics as well as the association [odds ratio (95% CI)] between the studied parameters with
foot ulceration
Without foot ulceration With foot ulceration P
n 258 121 —
Age (years) 60.0  11.7 63.2  10.2 0.86
Male/female n (%) 130 (50.4)/128 (49.6) 84 (69.4)/37 (30.6) 0.001
Type 1/type 2 diabetes n (%) 15 (5.8)/243 (94.2) 8 (6.6)/113 (93.4) 0.46
Duration of diabetes (years) [median value (IQR)] 10.0 (5.0–16.0) 18.0 (10.0–25.0) 0.001
A1C (%) 7.4  1.6 9.2  2.4 0.001
VPT (V) 21.5  11.6 37.4  12.2 0.001
VPT 25 V n (%) 85 (32.9) 101 (83.5) 0.001
NSS median value (IQR) 4.5 (0.0–6.0) 6.0 (4.0–7.0) 0.001
NDS median value (IQR) 2.0 (0.0–5.0) 7.0 (6.0–10.0) 0.001
NDS 6 n (%) 62 (24.0) 92 (76.0) 0.001
Monoﬁlament insensation n (%) 36 (14.0) 70 (57.9) 0.001
Neuropathy n (%) 114 (44.2) 114 (94.2) 0.001
Ankle-brachial pressure index 1.00  0.22 0.98  0.22 0.050
Peripheral artery disease n (%) 42 (16.3) 31 (25.6) 0.09
Abnormal Neuropad result n (%) 135 (52.3) 115 (95.0) 0.001
Univariate analysis OR 95% CI
Age (1 year) 1.00 0.98–1.02 0.56
Sex (male vs. female) 1.83 1.14–2.95 0.01
Duration of diabetes (1 year) 1.08 1.05–1.11 0.001
A1C (1%) 1.32 1.18–1.74 0.002
NSS (1 unit) 1.24 1.13–1.36 0.001
NDS (1 unit) 1.61 1.45–1.79 0.001
NDS 6 vs. 6 10.7 6.25–18.40 0.001
VPT (1 V) 1.10 1.08–1.13 0.001
VPT 25 vs. 25 V 12.23 6.20–22.68 0.001
Monoﬁlament result (insensation vs. sensation) 8.33 4.18–16.59 0.001
Neuropad result (abnormal vs. normal) 17.3 7.36–40.8 0.001
Peripheral artery disease (yes vs. no) 1.84 1.07–3.10 0.02
Multivariate analysis*
Model 1
NDS 6 vs. 6 6.70 3.31–13.35 0.001
Model 2
VPT 25 vs. 25 V 11.91 6.03–21.86 0.001
Model 3
Monoﬁlament result (insensation vs. sensation) 6.40 3.09–13.28 0.001
Model 4
Neuropad result (abnormal vs. normal) 16.28 6.27–38.24 0.001
DataaremeansSDunlessotherwiseindicated.IQR,interquartilerange.Sex,NDS6vs.6,VPT25vs.25V,monoﬁlamentresult(insensationvs.sensation),
Neuropad result (abnormal vs. normal), and peripheral artery disease (yes vs. no) were analyzed as categorical variables; all the other variables were analyzed as
continuousvariablesinbothunivariateandmultivariateanalysis.*Eachoneofthemodels1–4wereadjustedinadditionforage,sex,durationofdiabetes,A1C,NSS,
and peripheral artery disease status.
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with normal nerve conduction velocities
(9).Weshowedthatdrynessoftheskinof
the feet was detected in 95% of the pa-
tients with foot ulceration using the Neu-
ropad test. These ﬁndings agree with
previous data showing sudomotor dys-
function assessed with the sympathetic
skin response in the vast majority of pa-
tients with foot ulceration (10).
Noteworthy, the comparison of the
values of the areas under the ROC curves
demonstratedthattheresultsobtainedby
Neuropad testing are as informative as
those obtained by determination of other
neurological modalities commonly used
for the prediction of foot ulceration such
as VPT, NDS, and monoﬁlament testing.
Identiﬁcation of patients at risk for
foot ulceration using simple and reliable
methods is of clinical relevance. The
American Diabetes Association recom-
mends the combined use of simple tests
including pinprick, temperature, vibra-
tion, and 10-g monoﬁlament perception
as well as ankle reﬂexes for this purpose
(11). Our ﬁndings suggest that the Neu-
ropadcanbeincludedinthescreeningtests
forthepredictionoffootulceration.Advan-
tages of the Neuropad are its simplicity,
wide availability, high performance for the
diagnosis of peripheral neuropathy, and
high reproducibility (5,12). Moreover, the
test can be self-performed and evaluated
safely by the patients (13).
This is a cross-sectional study and a
casual relationship between the moisture
status of the skin of the feet, and foot ul-
ceration cannot be established. Moreover,
although the odds ratio is large, suggesting
that there is an association between an ab-
normal Neuropad response and foot ulcer-
ation,theCIsarewide,anditisnecessaryto
be cautious about the interpretation of the
ﬁnding.
In summary, dryness of the skin of
thefeetassessedbytheNeuropadtestcor-
relates with foot ulceration. This ﬁnding,
if conﬁrmed prospectively, suggests that
the Neuropad may be included in the
screening tests for the prediction of foot
ulceration in subjects with diabetes.
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